Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page
- Check3 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, signaling a new page version rather than a content change.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants', and the header text was standardized from 'Intervention / Treatment' to 'Intervention/Treatment' with a new revision label 'Revision: v3.6.0'. Additionally, new help sections were added: 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page revision tag has been updated from v3.5.4 to v3.5.5, signaling a minor update to the page. The study details and visible content remain unchanged.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor internal update. No substantive study content changes are indicated by this modification.SummaryDifference0.1%

- Check67 days agoChange DetectedUpdated the page’s displayed application/release version indicator from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check74 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.